top of page

AIMT

Aimmune Therapeutics

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$358.4M

Burn Rate (Qtr)

-$69.2M

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1' 20

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Create Free Account Now

Loading Catalysts...

search in progress

Pipeline powered by

AIMT

BPIQ_Logo_RGB-01.jpg

Company Profile

Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies.

Recent Posts

See what the community is saying - click to see full post.

AIMT - Nestlé announces results of tender offer for Aimmune Therapeutics, Inc.

AIMT - Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science

Jackpot

AIMT - AR101 Peanut Allergy PDUFA Date (Q1 '20)

bottom of page